Center types in Kansas
Regional Neurology Group (2)
Academic MS Center (1)
Filter by type:All (3)Regional Neurology Group (2)Academic MS Center (1)
67% of MS centers in Kansas are classified as Regional Neurology Group facilities.
Centers with Most Active Trials in Kansas
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
2. Advent Neurology Clinic1 trials
MS Care by City
Roeland Park1
Overland Park1
Kansas City1
Compare MS Centers in Kansas
| Center | Type | Infusion | Virtual | Experience |
|---|---|---|---|---|
Advent Neurology Clinic Roeland Park | Regional Neurology Group | ✓ | — | 2.6/5 |
| Regional Neurology Group | — | — | 3/5 | |
| Academic MS Center | — | — | 3.6/5 |
Advent Neurology Clinic
Roeland Park • Regional Neurology Group
Infusion
✓
Virtual
—
Experience
2.6/5
Kansas City Multiple Sclerosis Center, College Park Neurology
Overland Park • Regional Neurology Group
Infusion
—
Virtual
—
Experience
3/5
The University of Kansas Medical Center (KUMC)
Kansas City • Academic MS Center
Infusion
—
Virtual
—
Experience
3.6/5
Active MS clinical trials in Kansas
See all 27 trials →ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Kansas City
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Kansas City
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Kansas City · Roeland Park
ActivePhase 3
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Kansas City
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Kansas City · Overland Park
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Overland Park
ActivePhase 3
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
TG Therapeutics, Inc.
Kansas City
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Kansas City
Check out the MS Buddy App
It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
